Navigation Links
Gene therapy treatment extends lives of mice with fatal disease, MU study finds
Date:7/16/2012

COLUMBIA, Mo. A team of University of Missouri researchers has found that introducing a missing gene into the central nervous system could help extend the lives of patients with Spinal Muscular Atrophy (SMA) the leading genetic cause of infantile death in the world.

SMA is a rare genetic disease that is inherited by one in 6,000 children who often die young because there is no cure. Children who inherit SMA are missing a gene that produces a protein which directs nerves in the spine to give commands to muscles.

The MU team, led by Christian Lorson, professor in the Department of Veterinary Pathobiology and the Department of Molecular Microbiology and Immunology, introduced the missing gene into mice born with SMA through two different methods: intravenously and directly into the mice's central nervous systems. While both methods were effective in extending the lives of the mice, Lorson found that introducing the missing gene directly into the central nervous system extended the lives of the mice longer.

"Typically, mice born with SMA only live five or six days, but by introducing the missing SMN gene into the mice's central nervous systems, we were able to extend their lives 10-25 days longer than SMA mice who go untreated," said Lorson, who works in the MU Bond Life Sciences Center and the College of Veterinary Medicine. "While this system is still not perfect, what our study did show is that the direct administration of the missing gene into the central nervous system provides some degree of rescue and a profound extension of survival."

There are several different types of SMA that appear in humans, depending on the age that symptoms begin to appear. Lorson believes that introducing the missing gene through the central nervous system is a way to potentially treat humans regardless of what SMA type they have.

"This is a treatment method that is very close to being a reality for human patients," Lorson said. "Clinical trials of SMA treatment using gene therapy are likely to begin in next 12-18 months, barring any unforeseen problems."


'/>"/>

Contact: Nathan Hurst
hurstn@missouri.edu
573-882-6217
University of Missouri-Columbia
Source:Eurekalert

Related medicine news :

1. KRAS gene mutation and amplification status affects sensitivity to antifolate therapy
2. Antibody therapy prevents gastrointestinal damage following radiation exposure in mice
3. Chemotherapy proves life-saving for some leukemia patients who fail induction therapy
4. Immunotherapy for elderly cancer patients finds new promise in drug combination
5. Therapy exploits addiction of leukemia cells
6. Intensity Modulated Radiation Therapy optimal for localized prostate cancer
7. Adding drug to standard chemotherapy provides no survival benefit for older lung cancer patients
8. Study Casts Doubt on Value of Pricey Prostate Cancer Therapy
9. 19th century therapy for Parkinsons disease may help patients today
10. New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds
11. Xenotransplantation as a therapy for type 1 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2020)... ... 2020 , ... Devcool Inc ( http://www.devcool.com ), a ... its spin-off of HiPaaS, Inc ( http://www.hipaas.com ). HiPaaS Inc will focus ... growth and focuses on Healthcare consulting services. , With HiPaaS, companies can ...
(Date:1/24/2020)... ... January 24, 2020 , ... dicentra ... life sciences and food industries, is pleased to announce that Dr. Homa Assadi ... and research site in Toronto, Canada. , Dr. Assadi’s extensive experience pertains to ...
(Date:1/23/2020)... YORK (PRWEB) , ... January 23, 2020 , ... The ... Diversity” by Forbes and research firm Statista. , Mount Sinai was ranked No. 3 ... more than 20 industries. The Health System is New York City’s largest academic medical ...
(Date:1/23/2020)... ... January 23, 2020 , ... The American Heart Association ... announced that their Annual Ventura County Go Red for Women Luncheon will ... Four Seasons Westlake Village. Approximately 500 residents are anticipated to attend the premier event ...
(Date:1/23/2020)... ... ... SignatureCare Emergency Center is set to expand to North Dallas with the opening of ... of Lewisville, on 1596 W. Main St., Lewisville, TX 75067, the new location will ... It will serve residents and businesses around Lewisville, TX, including Double Oak, Copper Canyon, ...
Breaking Medicine News(10 mins):
(Date:1/25/2020)... ... January 25, 2020 , ... ... Vanessa Belozeroff, Executive Director, Global Program Management, Biosimilars Division of Amgen, has been ... , "Vanessa has over twenty five years of strategic global drug development and ...
(Date:1/24/2020)... GAITHERSBURG, Md. (PRWEB) , ... January 24, 2020 ... ... cloud-based business resilience solutions, announces z/Archive, a new low-cost object storage solution using ... with a simple and inexpensive way to move older data to cloud storage, ...
(Date:1/24/2020)... ... January 24, 2020 , ... Each year Therapy and Beyond, ... organizations to host Mom’s Mingles that are designed for 100+ moms of children with ... same journey, and ultimately, enjoy a night of carefree fun. The highly anticipated 3rd ...
Breaking Medicine Technology: